ClinicalTrials.Veeva

Menu

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer (RPOS+2)

C

Centre Antoine Lacassagne

Status and phase

Enrolling
Phase 2

Conditions

Localized Breast Cancer

Treatments

Radiation: Per-Operative Radiotherapy technique by Papillon +TM

Study type

Interventional

Funder types

Other

Identifiers

NCT04680715
2020/33

Details and patient eligibility

About

Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.

Enrollment

40 estimated patients

Sex

Female

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with invasive ductal adenocarcinoma <=2cm, evaluate on all radiological exams;
  • Women aged 65 years or older (patients 65 years of age in the year may be included);
  • Grade 1 or 2 unifocal adenocarcinoma, all index KI67, positive HR, negative HER2 status;
  • T0 or T1, N0 radio-clinic;
  • Operable patient with breast volume compatible with conservative surgery;
  • Patient with prior malignancy or other concurrent malignancies are eligible, including bilateral breast cancer
  • Patients who have been made aware of the information sheet and have given their written signed informed consent;
  • Patients benefitting from social health insurance coverage

Exclusion criteria

  • Age less than 65 years (except if 65 years obtained during the year)
  • Patient with an exclusive in situ carcinoma
  • Patient with lymphatic invasion / peri-nerve involvement / vascular emboli
  • Patient with a lobular adenocarcinoma
  • Patient with metastatic disease
  • Multifocal tumor
  • Patient with grade 3 or N+ disease
  • N1 proved by ultrasound guided
  • patient unable to express her consent
  • Patient deprived placed under the authority of a tutor
  • Female patients who are pregnant or breastfeeding
  • Vulnerable patient: as defined in article L1121-5 à -8

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Per-Operative Radiotherapy technique by Papillon +TM
Experimental group
Description:
Per-Operative Radiotherapy (1x20Gy) technique by Papillon +TM
Treatment:
Radiation: Per-Operative Radiotherapy technique by Papillon +TM

Trial contacts and locations

2

Loading...

Central trial contact

Frédérique JACQUINOT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems